Authors:
Schulz, TG
Thiel, R
Neubert, D
Brassil, PJ
Schulz-Utermoehl, T
Boobis, AR
Edwards, RJ
Citation: Tg. Schulz et al., Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies, BBA-PROT ST, 1546(1), 2001, pp. 143-155
Authors:
Schulz-Utermoehl, T
Mountfield, RJ
Madsen, K
Jorgensen, PN
Hansen, KT
Citation: T. Schulz-utermoehl et al., Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody, DRUG META D, 28(7), 2000, pp. 715-717
Authors:
Schulz-Utermoehl, T
Mountfield, RJ
Bywater, RP
Madsen, K
Jorgensen, PN
Hansen, KT
Citation: T. Schulz-utermoehl et al., Structure-function analysis of human CYP3A4 using a specific proinhibitoryantipeptide antibody, DRUG META D, 28(7), 2000, pp. 718-725
Authors:
Schulz-Utermoehl, T
Edwards, RJ
Boobis, AR
Citation: T. Schulz-utermoehl et al., Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens, DRUG META D, 28(5), 2000, pp. 544-551
Authors:
Schulz-Utermoehl, T
Bennett, AJ
Ellis, SW
Tucker, GT
Boobis, AR
Edwards, RJ
Citation: T. Schulz-utermoehl et al., Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression, PHARMACOGEN, 9(3), 1999, pp. 357-366